New Zealand, U.S. Researchers Develop Better Drug For Resistant TB
This article was originally published in PharmAsia News
Executive Summary
New Zealand scientists working with U.S. colleagues are enthusiastic about a new compound dubbed TBA-354, which they say is proving more effective than PA-824, to date considered the most-effective treatment for drug-resistant tuberculosis.